Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Jun 03, 2016 $26.29 $26.65 $25.08 $25.95 303 358
Jun 02, 2016 $23.74 $26.56 $23.63 $26.49 470 023
Jun 01, 2016 $23.69 $24.00 $22.63 $23.74 216 735
May 31, 2016 $23.41 $23.96 $23.17 $23.92 277 928
May 27, 2016 $22.28 $23.37 $21.98 $23.16 157 995
May 26, 2016 $22.06 $22.50 $21.38 $22.34 110 511
May 25, 2016 $21.54 $22.50 $21.31 $22.18 258 753
May 24, 2016 $20.58 $21.50 $20.18 $21.31 289 784
May 23, 2016 $20.69 $20.78 $20.28 $20.52 99 937
May 20, 2016 $20.62 $21.01 $20.04 $20.64 199 031
May 19, 2016 $19.16 $20.78 $19.03 $20.73 601 590
May 18, 2016 $18.22 $19.39 $18.21 $19.26 325 464
May 17, 2016 $19.38 $19.40 $18.27 $18.34 581 802
May 16, 2016 $19.27 $20.14 $18.77 $19.41 292 692
May 13, 2016 $17.58 $19.39 $17.58 $19.26 455 194
May 12, 2016 $18.49 $18.66 $17.23 $17.85 216 371
May 11, 2016 $18.81 $19.25 $18.06 $18.33 214 913
May 10, 2016 $19.40 $19.43 $18.25 $18.92 284 252
May 09, 2016 $18.34 $19.48 $18.01 $19.27 411 296
May 06, 2016 $18.59 $19.12 $17.91 $18.26 319 996
May 05, 2016 $19.75 $19.75 $18.28 $18.71 556 887
May 04, 2016 $20.69 $21.20 $19.08 $19.98 236 893
May 03, 2016 $20.51 $21.04 $20.07 $21.01 163 270
May 02, 2016 $20.17 $20.85 $19.95 $20.80 121 618
Apr 29, 2016 $20.90 $21.40 $19.33 $20.17 297 899
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT